Evidence map›Paper›PMID 31338550›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2019

Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer's disease with FDG-PET.

Dominik Blum, Inga Liepelt-Scarfone, Daniela Berg, Thomas Gasser, Christian la Fougère, Matthias Reimold, Alzheimer’s Disease Neuroimaging Initiative

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Artificial intelligence for molecular neuroimaging.Annals of translational medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Dominik BlumInstitute for Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University, Tuebingen, Germany. dominik.blum@med.uni-tuebingen.de.ORCID http://orcid.org/0000-0002-9135-3658
Inga Liepelt-ScarfoneGerman Center of Neurodegenerative Diseases, Eberhard Karls University, Tuebingen, Germany.
Daniela BergDepartment of Neurology, Christian-Albrechts-University, Kiel, Germany.
Thomas GasserGerman Center of Neurodegenerative Diseases, Eberhard Karls University, Tuebingen, Germany.
Christian la FougèreInstitute for Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University, Tuebingen, Germany.
Matthias ReimoldInstitute for Nuclear Medicine and Clinical Molecular Imaging, Eberhard Karls University, Tuebingen, Germany.
Alzheimer’s Disease Neuroimaging Initiative

Funding

Seventh Framework Programme (FP7/2007-2013) 603646
6 · The paper itself

Abstract

objectiveThe pattern expression score (PES), i.e., the degree to which a pathology-related pattern is present, is frequently used in FDG-brain-PET analysis and has been shown to be a powerful predictor of conversion to Alzheimer's disease (AD) in mild cognitive impairment (MCI). Since, inevitably, the PES is affected by non-pathological variability, our aim was to improve classification with the simple, yet novel approach to identify patterns of non-pathological variance in a separate control sample using principal component analysis and removing them from patient data (controls-based denoising, CODE) before calculating the PES.

methodsMulti-center FDG-PET from 220 MCI patients (64 non-converter, follow-up ≥ 4 years; 156 AD converter, time-to-conversion ≤ 4 years) were obtained from the ADNI database. Patterns of non-pathological variance were determined from 262 healthy controls. An AD pattern was calculated from AD patients and controls. We predicted AD conversion based on PES only and on PES combined with neuropsychological features and ApoE4 genotype. We compared classification performance achieved with and without CODE and with a standard machine learning approach (support vector machine).

resultsOur model predicts that CODE improves the signal-to-noise ratio of AD-PES by a factor of 1.5. PES-based prediction of AD conversion improved from AUC 0.80 to 0.88 (p= 0.001, DeLong's method), sensitivity 69 to 83%, specificity 81% to 88% and Matthews correlation coefficient (MCC) 0.45 to 0.66. Best classification (0.93 AUC) was obtained when combining the denoised PES with clinical features.

conclusionsCODE, applied in its basic form, significantly improved prediction of conversion based on PES. The achieved classification performance was higher than with a standard machine learning algorithm, which was trained on patients, explainable by the fact that CODE used additional information (large sample of healthy controls). We conclude that the proposed, novel method is a powerful tool for improving medical image analysis that offers a wide spectrum of biomedical applications, even beyond image analysis.

Indexed as

Image Processing, Computer-AssistedPositron-Emission TomographyAgedAlgorithmsAlzheimer DiseaseBrainCognitive DysfunctionDiagnosis, Computer-AssistedFemaleFluorodeoxyglucose F18HumansMachine LearningMaleMiddle AgedModels, TheoreticalPattern Recognition, AutomatedFluorodeoxyglucose F18DenoisingPattern expression scorePhysiological variancePrincipal component analysis

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.